Poolbeg Pharma (LON:POLB) Shares Down 19% – Here’s What Happened

Shares of Poolbeg Pharma PLC (LON:POLB) traded down 19% during mid-day trading on Friday . The stock traded as low as GBX 3.70 ($0.05) and last traded at GBX 3.89 ($0.05). 3,471,574 shares traded hands during mid-day trading, an increase of 0% from the average session volume of 3,471,285 shares. The stock had previously closed at GBX 4.80 ($0.06).

Wall Street Analysts Forecast Growth

Separately, Shore Capital reaffirmed a “house stock” rating on shares of Poolbeg Pharma in a report on Thursday, January 2nd.

Poolbeg Pharma Price Performance

The firm has a fifty day simple moving average of GBX 5.48 and a two-hundred day simple moving average of GBX 8.03. The firm has a market capitalization of £20.30 million, a P/E ratio of 0.00 and a beta of 2.11.

Poolbeg Pharma Company Profile

Poolbeg Pharma plc is focussed on the development and commercialisation of innovative medicines targeting serious diseases with a high unmet medical need. Its model focusses upon developing its exciting clinical assets and commercialising approved and marketed drugs to support the growth of the Company and the development of its robust pipeline of innovative products, thereby driving significant value creation.

Poolbeg is led by an experienced leadership team with a history of delivering significant shareholder value.